News
Professor Lotte Steuten Appointed OHE Vice President and Head of Consulting
8 January 2019
OHE is very pleased to announce that associate professor Lotte Steuten will be joining OHE in February as Vice-President and Head of Consulting. Lotte is currently…
Professor Mireia Jofre-Bonet Appointed Vice President and Head of Research
8 January 2019
OHE is very pleased to announce that Professor Mireia Jofre-Bonet will be joining OHE in April as Vice-President and Head of Research, replacing Professor Nancy Devlin…
Can a Strong Economic Case Be Made for Investing in the NHS? 25th Annual Lecture Publication
2 January 2019
In September 2018, Professor Peter Smith delivered the 25th OHE Annual Lecture. The lecture is now available as a publication, which can be downloaded for free.
OHE Achievements in 2018
27 December 2018
This year, the OHE team published 39 peer reviewed journal articles, gave 58 lectures and conference presentations, posted 22 in-house OHE publications on our website, and…
Making the Most of Health Data to Deliver Pharmaceutical Innovation: What Are the Legal Barriers?
20 December 2018
OHE publishes a report on the legal barriers to the better use of health data to deliver pharmaceutical innovation.
“You Don’t Always Get What You Want”: Output Distortion and NHS Waiting Time Targets
18 December 2018
The latest publication from Professor Graham Cookson in Public Organization Review finds that waiting time targets adopted in the English NHS as part of the ‘targets…
A Note on the Relationship Between Age and Health-related Quality of Life Assessment
12 December 2018
A new OHE-authored paper on the relationship between age and health-related quality of life has been published in Quality of Life Research.
New Publications: Real-World Evidence for Coverage and Formulary Decisions
7 December 2018
Two articles, published in the Journal of Comparative Effectiveness Research, explore the use of real-world evidence for coverage and formulary decisions.
New NICE Position Statement – 5L Value Set Still ‘On Hold’
29 November 2018
NICE has issued a new position statement regarding the use of the EQ-5D-5L value set in evidence submitted to its HTA process.